Loading…
Tandem Diabetes Care, Inc. is projected to decline to $13.70 by 2027, a -8% move from its current price of $14.82. TNDM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $14.20 | $14.81 | $15.45 | -0.06% |
| May 30 | $13.94 | $14.80 | $15.72 | -0.13% |
| May 31 | $13.74 | $14.79 | $15.92 | -0.19% |
| Jun 1 | $13.58 | $14.78 | $16.09 | -0.26% |
| Jun 2 | $13.44 | $14.77 | $16.24 | -0.32% |
| Jun 3 | $13.31 | $14.76 | $16.38 | -0.38% |
| Jun 4 | $13.19 | $14.75 | $16.51 | -0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.19 | $14.75 | $16.51 | -0.45% |
| Week 2 | $12.53 | $14.69 | $17.21 | -0.89% |
| Week 3 | $12.04 | $14.62 | $17.76 | -1.34% |
| Week 4 | $11.63 | $14.56 | $18.22 | -1.78% |
| Week 5 | $11.28 | $14.49 | $18.62 | -2.22% |
| Week 6 | $10.96 | $14.43 | $18.99 | -2.65% |
| Week 7 | $10.67 | $14.36 | $19.33 | -3.09% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tandem Diabetes Care, Inc. is a healthcare company that designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. Its flagship products are the t:slim X2 insulin delivery system and Tandem Mobi insulin pump, an automated insulin delivery system.
The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body.
Tandem Diabetes Care, Inc. is currently trading at $14.97 per share. Its market capitalization is $1.03B, and it ranks 2526. The near-term outlook is reflected in the year-by-year forecast, which shows a flat average for 2026 at $14.97 with a min of $12.82 and a max of $17.92, yielding an ROI of 0% and a NEUTRAL sentiment.
A major floor 46.9% below — a decisive break under it would weaken the trend.
The nearest floor, 13.5% below — buyers have tended to step in here.
The nearest ceiling, 43.3% above — a clean break opens room to run.
A major ceiling 90.7% above — clearing it would confirm fresh momentum.
Key TNDM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TNDM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.03 | Sell | $14.77 | Buy |
| MA 10 | $14.36 | Buy | $14.97 | Sell |
| MA 20 | $16.07 | Sell | $15.94 | Sell |
| MA 50 | $19.06 | Sell | $18.03 | Sell |
| MA 100 | $20.24 | Sell | $19.02 | Sell |
| MA 200 | $18.05 | Sell | $19.66 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.33 | Neutral |
| Stoch RSI (14) | 83.35 | Sell |
| CCI (20) | -40.91 | Neutral |
| Williams %R (14) | -64.60 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | -4.26 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 35.40 | Neutral |
| TRIX (15) | -1.18 | Sell |
| Awesome (5,34) | -2.75 | Sell |
| Ultimate (7,14,28) | 56.68 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 15.26 | Sell |
| ADX (14) | 23.91 | Sell |
| ATR (14) | 0.70 | Info |
The 30-day technical picture is NEUTRAL, with an RSI14 of 40. The stock trades below the short- and mid-term moving averages, as the SMA50 is $19.34 and the SMA200 is $18.02, indicating only modest near-term momentum. The chart shows a 30-day range from $11.16 to $20.07, with support at $12.82 and resistance at $21.24, framing potential pullbacks or rallies within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $12.82 | $14.82 | $17.63 | 0% | Neutral | |
| $10.29 | $13.70 | $19.64 | -8% | Neutral | |
| $8.62 | $12.01 | $18.11 | -19% | Bearish | |
| $9.28 | $13.44 | $21.10 | -9% | Neutral | |
| $11.25 | $16.85 | $27.36 | +14% | Neutral | |
| $11.33 | $17.54 | $29.31 | +18% | Neutral | |
| $11.94 | $19.04 | $32.65 | +28% | Bullish | |
| $10.26 | $16.84 | $29.57 | +14% | Neutral | |
| $9.18 | $15.48 | $27.77 | +4% | Neutral | |
| $11.55 | $20.02 | $36.62 | +35% | Bullish | |
| $11.97 | $23.54 | $46.74 | +59% | Bullish | |
| $20.93 | $46.51 | $103.81 | +214% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $12.82 | $14.82 | $17.56 | +0.00% |
| June 2026 | $12.24 | $14.55 | $17.83 | -1.84% |
| July 2026 | $11.61 | $13.98 | $17.49 | -3.90% |
| August 2026 | $11.59 | $14.10 | $17.92 | +0.87% |
| September 2026 | $11.34 | $13.92 | $17.91 | -1.28% |
| October 2026 | $10.54 | $13.04 | $16.97 | -6.33% |
| November 2026 | $10.28 | $12.81 | $16.84 | -1.75% |
| December 2026 | $10.59 | $13.29 | $17.63 | +3.73% |
Click any year to see its month-by-month TNDM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Tandem Diabetes Care, Inc.'s 2026 outlook centres on $14.82, within a $12.82 to $17.63 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, TNDM could reach as high as $19.64, with a base case around $13.70 and support toward $10.29 — roughly -8% from $14.82. A consolidation phase looks the most probable path here.
Expect TNDM to range from $8.62 to $18.11 through 2028. The $12.01 average target implies a -19% move from current prices. That is -12% versus the projected 2027 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The TNDM price prediction for 2029 points to an average of $13.44 (low $9.28, high $21.10) — a potential decline of -9% on today's $14.82. A consolidation phase looks the most probable path here.
In 2030, TNDM is projected to trade between $11.25 and $27.36, averaging $16.85 — a potential gain of +14% from today's $14.82. That is up +25% on the projected 2029 average. Price action looks broadly range-bound.
Tandem Diabetes Care, Inc.'s 2031 outlook centres on $17.54, within a $11.33 to $29.31 range. That is up +4% on the projected 2030 average. That marks a +18% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, TNDM could reach as high as $32.65, with a base case around $19.04 and support toward $11.94 — roughly +28% from $14.82. Momentum favours further upside here.
Expect TNDM to range from $10.26 to $29.57 through 2033. The $16.84 average target implies a +14% move from current prices. That is -12% versus the projected 2032 average. A consolidation phase looks the most probable path here.
The TNDM price prediction for 2034 points to an average of $15.48 (low $9.18, high $27.77) — a potential gain of +4% on today's $14.82. Price action looks broadly range-bound.
In 2035, TNDM is projected to trade between $11.55 and $36.62, averaging $20.02 — a potential gain of +35% from today's $14.82. That is up +29% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Tandem Diabetes Care, Inc.'s 2040 outlook centres on $23.54, within a $11.97 to $46.74 range. That is up +18% on the projected 2035 average. That marks a +59% change versus current levels. Momentum favours further upside here.
By 2050, TNDM could reach as high as $103.81, with a base case around $46.51 and support toward $20.93 — roughly +214% from $14.82. Buyers look set to stay in control over this stretch.
Investing $1,000 in TNDM today (≈ 67.476383 TNDM) could be worth
$3,138.36
+$2,138.36 (+214%) by 2050 · US Dollar
Based on the average projected TNDM price of $46.51 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TNDMwould be worth at today's price.
$1,000 invested in TNDM on May 27, 2025 (≈ 46.554936 TNDM) would be worth
$689.94
-$310.06 (-31.0%) today · 0.69× · US Dollar
Based on a TNDM entry price of $21.48 vs. today's $14.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.04 | $985.37 | -1.5% |
| 1 month ago | $19.82 | $747.73 | -25.2% |
| 3 months ago | $25.79 | $574.64 | -42.5% |
| 6 months ago | $21.01 | $705.38 | -29.5% |
| 1 year ago | $21.48 | $689.94 | -31.0% |
| All time (5.0y) ago | $84.07 | $176.28 | -82.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TNDM forecast.
Our base-case forecast reaches $30.00 around 2050.
Implied market cap at $30.00: $2.06B
The multi-year forecast depicts a rising long-term path, with 2030 showing an average price of $17.23 and a 15.2% ROI, while sentiments in that period remain NEUTRAL. The forecast also projects 2040 at an average of $24.14 with a 61.3% ROI and a BULLISH sentiment, and 2050 at an average of $48.01 with a 220.8% ROI and a BULLISH sentiment. Earlier years show a more mixed path, including 2027 with an average of $13.70 and -8.5% ROI (NEUTRAL), 2028 with $12.09 and -19.2% ROI (BEARISH), and 2032 with $19.43 and 29.9% ROI (BULLISH).
These figures illustrate a long-run upside potential alongside near-term volatility; they are estimates, not guarantees.
Tap a question to reveal the answer.
The forecast for 2030 shows an average of $17.23 with a min of $11.32 and a max of $28.39, and a ROI of 15.2%. The sentiment is NEUTRAL.
Forecasts indicate mixed results over the coming years, with 2026 average of $14.97 (ROI 0%), 2027 average $13.70 (ROI -8.5%), 2028 average $12.09 (ROI -19.2%), and longer-term upside in 2030 ($17.23, ROI 15.2%) and beyond (e.g., 2050 with ROI 220.8%). These are estimates and not guarantees.
Yes, the long-horizon max in 2050 is $109.76, and the 2040 max is $48.94, with the 2050 average at $48.01. The forecast shows scenarios where higher price levels could occur, but these are not guarantees.
The current price is $14.97.
The 30-day range is from $11.16 to $20.07.
Tandem Diabetes Care, Inc. Community Discussion
0Share your Tandem Diabetes Care, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.